Intech Investment Management LLC Acquires New Holdings in agilon health, inc. (NYSE:AGL)

Intech Investment Management LLC bought a new position in shares of agilon health, inc. (NYSE:AGL) during the third quarter, according to its most recent Form 13F filing with the SEC. The fund bought 57,967 shares of the company’s stock, valued at approximately $228,000.

Several other institutional investors and hedge funds have also recently added to or reduced their stakes in the business. J.Safra Asset Management Corp boosted its holdings in agilon health by 626.1% in the second quarter. J.Safra Asset Management Corp now owns 4,204 shares of the company’s stock valued at $27,000 after acquiring an additional 3,625 shares during the last quarter. City State Bank bought a new stake in shares of agilon health in the 3rd quarter valued at $52,000. CWM LLC increased its position in shares of agilon health by 406.5% during the second quarter. CWM LLC now owns 9,081 shares of the company’s stock worth $59,000 after buying an additional 7,288 shares during the period. Nisa Investment Advisors LLC bought a new stake in agilon health during the second quarter valued at $60,000. Finally, Allspring Global Investments Holdings LLC grew its holdings in agilon health by 17,790.0% during the 2nd quarter. Allspring Global Investments Holdings LLC now owns 10,734 shares of the company’s stock worth $70,000 after acquiring an additional 10,674 shares during the period.

agilon health Stock Performance

AGL stock opened at $2.21 on Friday. agilon health, inc. has a one year low of $1.50 and a one year high of $13.76. The firm has a market cap of $910.56 million, a price-to-earnings ratio of -2.35 and a beta of 0.51. The company has a debt-to-equity ratio of 0.06, a quick ratio of 1.29 and a current ratio of 1.29. The firm has a 50-day simple moving average of $2.63 and a two-hundred day simple moving average of $4.56.

agilon health (NYSE:AGL) last released its earnings results on Thursday, November 7th. The company reported ($0.29) EPS for the quarter, missing analysts’ consensus estimates of ($0.10) by ($0.19). The company had revenue of $1.45 billion during the quarter, compared to analyst estimates of $1.47 billion. agilon health had a negative return on equity of 47.84% and a negative net margin of 6.88%. During the same quarter last year, the business earned ($0.06) earnings per share. On average, equities analysts forecast that agilon health, inc. will post -0.47 EPS for the current fiscal year.

Analyst Upgrades and Downgrades

Several brokerages have recently commented on AGL. Citigroup reduced their target price on agilon health from $2.50 to $1.75 and set a “sell” rating for the company in a research note on Wednesday, November 13th. Benchmark reaffirmed a “buy” rating and set a $9.00 price objective on shares of agilon health in a report on Thursday, August 8th. Royal Bank of Canada reaffirmed an “outperform” rating and issued a $3.00 price objective on shares of agilon health in a research report on Tuesday, November 19th. TD Cowen reduced their price objective on agilon health from $6.00 to $2.00 and set a “hold” rating for the company in a research note on Monday, November 11th. Finally, Evercore ISI lowered their price target on shares of agilon health from $7.00 to $4.00 and set an “in-line” rating on the stock in a report on Tuesday, October 8th. Three investment analysts have rated the stock with a sell rating, fifteen have given a hold rating and two have assigned a buy rating to the company’s stock. Based on data from MarketBeat.com, the stock presently has an average rating of “Hold” and an average price target of $6.05.

Insider Buying and Selling

In other agilon health news, CEO Steven Sell acquired 20,000 shares of the business’s stock in a transaction dated Thursday, September 12th. The stock was acquired at an average cost of $3.36 per share, for a total transaction of $67,200.00. Following the completion of the transaction, the chief executive officer now directly owns 67,590 shares of the company’s stock, valued at $227,102.40. This represents a 42.03 % increase in their ownership of the stock. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Corporate insiders own 3.20% of the company’s stock.

About agilon health

agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.